| abstract |
The invention relates to acino-fetal differentiation proteins associated with pancreatic cancer, characterized in that they are manosidated glycoproteins, of average apparent molecular mass chosen from: 120 KD, 94 KD and 58 KD.n n n The invention also relates to a method for the preparation of these proteins, an antiserum against these proteins and its method of preparation, monoclonal antibodies against these proteins and their method of preparation and compositions for diagnostic or therapeutic use containing these proteins or antibodies. |